At the beginning of July, USP Zdrowie Group acquired 100% of shares in the Polish-Swedish Naturell Group. This transaction indicates the potential strength of Polish pharmaceutical companies that are entering highly developed and advanced markets such as the Nordic market. The investment has enabled USP Zdrowie to significantly increase its share of the growing dietary supplements market in Poland. Although this highly demanding direction for foreign expansion of Polish entrepreneurs was until recently rare, it is now becoming more commonplace.

DZP was the main adviser and co-ordinated the Polish-Swedish team of lawyers and tax and financial advisers and was responsible for the legal side of the transaction.

The client was advised by a team of lawyers: Bartosz Marcinkowski, Marcin Kuliński and Magdalena Purol (corporate), Tomasz Kaczyński, Michał Tracz and Sabina Sztaba (regulatory and pharmaceutical law) and Jarosław Konecko (intellectual property).

The advice was provided to USP Zdrowie within the DZP Go Global project, which is aimed at helping Polish entrepreneurs wishing to invest abroad. Our know-how, experience and extensive international contacts serve entrepreneurs well and our clients’ successes are our successes too. We are pleased to see growing expansion onto markets that until recently were almost entirely closed to Polish entrepreneurs said Bartosz Marcinkowski, who is heading the DZP Go Global project.  

USP Zdrowie is among the largest Polish companies specialising in OTC products. If USP Zdrowie continues to sell the Swedish company’s products, it may become no. 3 on the supplements market in the pharmacy channel.

This is of course not DZP’s first transaction on the dietary supplements market. A year ago a multi-disciplinary team of DZP lawyers dealing with pharmaceutical law and M&A advised on the sale of Sequoia to the food company Maspex: http://en.dzp.pl/deals-corner/1505-dzp-advises-pharmaceutical-company-owners-in-a-merger-with-fmcg-market-leader.